Form 4 for BC BRUNSWICK CORP
Accepted 2023-11-01 00:00:00 ET · period of report 2023-10-31 · accession 0000014930-23-000194 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-01 | 2023-10-31 | BC | SINGER DAVID V | Dir | A - Grant | $69.47 | +1,084 | 24.0K | +5% | +$75.3K | |
| 2023-11-01 | 2023-11-01 | BC | SINGER DAVID V | Dir | S - Sale | $68.67 | -221 | 23.8K | -0.9% | -$15.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-31 | A | A | 1,084 | $69.47 | 23,996 | D | — | — | (F1) 454 of these shares are deferred shares deposited in the director's deferred account, which will be automatically distributed in predetermined installments after the director ceases being a director of the Company. (F2) Beneficial holdings include 104 shares acquired pursuant to dividend reinvestment in September 2023. |
| 2 | Common | Common Stock | 2023-11-01 | S | D | 221 | $68.67 | 23,775 | D | — | — |